Vietnam Drug Maker Develops New Cholera Vaccine
This article was originally published in PharmAsia News
Executive Summary
Vietnam's Vaccine and Bio-Technology Products No. 1 says it has developed a cholera vaccine that is half again as effective as current drugs. The drug, being registered as mORACVAX, is expected to gain approval in time to treat a new outbreak of the disease. The director of Vietnam's National Institute of Hygiene and Epidemiology said the vaccine is 90 percent to 100 percent effective, compared with the 60 percent to 70 percent effectiveness of the current vaccine. The vaccine is expected to cost about $1.25 per dose, triple the cost of the current drug being administered. (Click here for more